U.S. inspectors listed serious problems in 2022 that could have resulted in strict measures like a pause in production. But the plant continued operating, and some conditions persisted.
Christina Jewett and Teddy Rosenbluth | NYTimes Health | Disclosure
Comments
Post a Comment